MONTRÉAL, April 09, 2022 (GLOBE NEWSWIRE) -- P. Peter Pascali, President and Chief Executive Officer of PyroGenesis Canada Inc. (http://pyrogenesis.com) (TSX: PYR) (NASDAQ: PYR) (FRA: 8PY) (“ PyroGenesis ”), a high-tech company that designs, develops, manufactures and commercializes plasma atomized metal powders, environmentally friendly plasma waste-to-energy systems and clean plasma torch products, has filed today an updated early warning report with respect to his shareholdings in PyroGenesis in connection with his proposed disposition (the “ Proposed Disposition ”) through the facilities of the Toronto Stock Exchange of up to 750,000 common shares of PyroGenesis (“ Common Shares ”) held by Fiducie de Crédit Mellon Trust (the “ Trust ”) under an automatic securities disposition plan (“ ASDP ”) and a notice of intention to distribute securities (Form 45-102F1) filed by Mr. Pascali and available under the SEDAR profile of PyroGenesis at www.sedar.com.

The Common Shares to be sold under the Proposed Disposition would be sold for the purposes of allowing for Mr. Pascali to make tax payments and reducing debt. The ASDP will allow for an orderly disposition of a small portion of the Common Shares held or controlled by Mr. Pascali at prevailing market prices during the period from April 18, 2022 to May 6, 2022.

Sales under the ASDP will be effected by an independent securities broker in accordance with general trading parameters set out in the ASDP, and Mr. Pascali is not permitted to exercise any further discretion or influence over how dispositions will occur under the ASDP. Dispositions pursuant to the ASDP will be reported by Mr. Pascali on SEDI in accordance with applicable Canadian securities legislation.

On April 8, 2022, a total of 170,125,795 Common Shares were issued and outstanding. As of April 8, 2022, prior to any sales under the Proposed Disposition, Mr. Pascali (i) beneficially owns and controls 63,742,941 Common Shares (representing 37.47% of the issued and outstanding Common Shares), (ii) controls 7,251,000 Common Shares beneficially owned by 8339856 Canada Inc. (the “ Holdco ”) (representing 4.26% of the issued and outstanding Common Shares), (iii) controls 6,750,557 Common Shares beneficially owned by the Trust (representing 3.97% of the issued and outstanding Common Shares), and (iv) controls 2,000,000 Common Shares beneficially owned by The 2% Solution Foundation (the “ Foundation ”). This represents, in aggregate (the “ Total Ownership ”), 79,744,498 Common Shares, or 46.87% of the issued and outstanding Common Shares.

Assuming the completion of the Proposed Disposition, 750,000 Common Shares, representing 0.44% of the issued and outstanding Common Shares, will be sold by the Trust, resulting in a Total Ownership of 78,994,498 Common Shares (representing 46.43% of the issued and outstanding Common Shares).

In addition, Mr. Pascali beneficially owns and controls options issued under PyroGenesis’ option plan to acquire 5,920,000 Common Shares (of which 5,270,000 are currently vested (the “ Vested Options ”) and, 325,000 will vest on July 16, 2022 and 325,000 will vest on July 16, 2023 (the unvested options, collectively, the “ Unvested Options ”).

Assuming the exercise of all the Vested Options, an aggregate of 5,270,000 Common Shares would be issued, and the Total Ownership would increase to 85,014,498 Common Shares (or 84,264,498 Common Shares assuming the completion of the Proposed Disposition), or 48.47% (or 48.04% assuming the completion of the Proposed Disposition) of the issued and outstanding Common Shares (based on the number of Common Shares issued and outstanding as of the date hereof and after giving effect to the issuance of the 5,270,000 Common Shares issuable under such options). Of such Total Ownership of 85,014,498 Common Shares, (i) 69,012,941 Common Shares would be beneficially owned and controlled by Mr. Pascali, (ii) 7,251,000 Common Shares would be controlled by Mr. Pascali and beneficially owned by the Holdco, (iii) 6,750,557 Common Shares (or 6,000,557 Common Shares assuming the completion of the Proposed Disposition) would be controlled by Mr. Pascali and beneficially owned by the Trust, and (iv) 2,000,000 Common Shares would be controlled by Mr. Pascali and beneficially owned by the Foundation.

Assuming the exercise of the Vested Options and the Unvested Options, an aggregate of 5,920,000 Common Shares would be issued, and the Total Ownership would increase to 85,664,498 Common Shares, or 48.66% of the issued and outstanding Common Shares (based on the number of Common Shares issued and outstanding as of the date hereof and after giving effect to the issuance of the 5,920,000 Common Shares issuable under such options). Of such Total Ownership of 85,664,498 Common Shares, (i) 69,662,941 Common Shares would be beneficially owned and controlled by Mr. Pascali, (ii) 7,251,000 Common Shares would be controlled by Mr. Pascali and beneficially owned by the Holdco, (iii) 6,750,557 Common Shares (or 6,000,557 Common Shares assuming the completion of the Proposed Disposition) would be controlled by Mr. Pascali and beneficially owned by the Trust, and (iv) 2,000,000 Common Shares would be controlled by Mr. Pascali and beneficially owned by the Foundation.

The Trust, the Holdco and the Foundation may be considered to be joint actors with Mr. Pascali. Mr. Pascali is a (i) trustee, executive officer and beneficiary of the Trust, (ii) director, executive officer and the sole shareholder of the Holdco, and (iii) director of the Foundation.

Mr. Pascali and any joint actor may, from time to time, acquire or dispose of ownership or control or direction over some or all of the securities of PyroGenesis depending on a number of factors.

For further information, including regarding the early warning report, including a copy of same (which is available under PyroGenesis’ SEDAR profile at www.sedar.com), please contact:

P. Peter Pascali, President and Chief Executive Officer of PyroGenesis, at 514-937-0002. The address of the head office of PyroGenesis is 1744 William Street, Suite 200, Montreal, Quebec, H3J 1R4.